MAXYGEN INC
S-3/A, EX-23.1, 2001-01-19
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: MAXYGEN INC, S-3/A, EX-5.1, 2001-01-19
Next: MAXYGEN INC, S-3/A, EX-23.2, 2001-01-19



<PAGE>

                                                                    Exhibit 23.1

              CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


We consent to the reference to our firm under the caption "Experts" in Amendment
No. 1 to the Registration Statement (Form S-3) and related Prospectus of
Maxygen, Inc. for the registration of 209,500 shares of its common stock and to
the incorporation by reference therein of our report dated February 18, 2000,
with respect to the financial statements of Maxygen, Inc. included in its Annual
Report (Form 10-K) for the year ended December 31, 1999, filed with the
Securities and Exchange Commission.
                                             /s/ Ernst & Young LLP

Palo Alto, California


January 18, 2001



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission